awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38791215-364D9C11-A010-4BBC-951C-21CBCC212C19
Q38791215-364D9C11-A010-4BBC-951C-21CBCC212C19
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38791215-364D9C11-A010-4BBC-951C-21CBCC212C19
Pharmacogenomics of second-line drugs used for treatment of unresponsive or relapsed osteosarcoma patients.
P2860
Q38791215-364D9C11-A010-4BBC-951C-21CBCC212C19
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38791215-364D9C11-A010-4BBC-951C-21CBCC212C19
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
74f207eb5fa22b7642d1a57586dd44653aa72d31
P2860
Resistance to bleomycin in cancer cell lines is characterized by prolonged doubling time, reduced DNA damage and evasion of G2/M arrest and apoptosis.